FEBS Journal

Scope & Guideline

Fostering Knowledge and Innovation in Biochemical Sciences

Introduction

Explore the comprehensive scope of FEBS Journal through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore FEBS Journal in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1742-464x
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2005 to 2024
AbbreviationFEBS J / FEBS J.
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The FEBS Journal publishes high-quality research articles that span a wide range of topics in biochemistry, molecular biology, and cellular biology. The journal aims to advance our understanding of biological processes at the molecular level, with a focus on the mechanisms underlying disease and potential therapeutic interventions.
  1. Biochemical and Molecular Mechanisms:
    The journal emphasizes studies that elucidate the biochemical pathways and molecular mechanisms underpinning cellular functions and disease processes, including signaling pathways, metabolic regulation, and enzyme function.
  2. Structural Biology and Biophysics:
    Research involving the structural characterization of biological macromolecules such as proteins and nucleic acids, utilizing techniques like X-ray crystallography, NMR, and cryo-electron microscopy, is a core focus.
  3. Cellular and Developmental Biology:
    The journal covers research on cellular processes, including cell differentiation, growth, and apoptosis, as well as developmental biology, exploring how these processes are regulated at the molecular level.
  4. Cancer Biology and Therapeutics:
    A significant emphasis is placed on studies related to cancer biology, including tumor microenvironment interactions, cancer stem cells, and novel therapeutic strategies.
  5. Immunology and Microbiology:
    The journal publishes articles on immune responses, pathogen-host interactions, and the microbiome's role in health and disease, reflecting the growing interest in these areas.
  6. Neurobiology and Neurodegeneration:
    Research addressing the molecular mechanisms of neurodegenerative diseases, neuroinflammation, and neuronal signaling is prominently featured, highlighting the journal's commitment to understanding brain health.
The FEBS Journal has experienced a notable evolution in its focus areas, with several emerging themes reflecting current scientific trends and societal needs. These trends indicate a shift towards more interdisciplinary and applied research.
  1. Cancer Immunotherapy:
    Publications focusing on cancer immunotherapy have surged, highlighting the importance of understanding immune responses to tumors and the development of novel immunotherapeutic strategies.
  2. Microbiome Research:
    The role of the microbiome in health and disease is increasingly prominent, with studies examining its impact on various physiological processes and its potential as a therapeutic target.
  3. Cellular Senescence and Aging:
    Research on cellular senescence, its role in aging, and its implications for age-related diseases is gaining traction, reflecting a growing interest in understanding the biological mechanisms of aging.
  4. Gene Editing Technologies:
    The application of CRISPR and other gene editing technologies is increasingly featured, focusing on their potential for therapeutic interventions and understanding genetic diseases.
  5. Metabolism and Disease:
    Emerging studies on the links between metabolism, metabolic disorders, and diseases such as cancer and neurodegeneration are becoming more common, emphasizing the importance of metabolic pathways in health.
  6. Extracellular Vesicles:
    Research on extracellular vesicles and their roles in cell communication, disease progression, and potential therapeutic applications is gaining popularity, reflecting their significance in various biological processes.

Declining or Waning

While the FEBS Journal has maintained a broad focus on various aspects of biochemistry and molecular biology, certain themes appear to be declining in prominence over recent years. This may reflect shifts in research priorities or emerging fields of interest.
  1. Basic Enzyme Kinetics:
    Research focusing solely on basic enzyme kinetics has seen a decline, as the field increasingly emphasizes the integration of kinetic studies with structural biology and functional assays.
  2. Traditional Pharmacology:
    There is a noticeable reduction in studies centered on traditional pharmacological approaches, as the focus shifts towards molecular and genetic therapies, particularly in the context of cancer and chronic diseases.
  3. Plant Biochemistry:
    While still relevant, the volume of research specifically addressing plant biochemistry and physiology appears to be waning, potentially due to a shift towards more applied or translational research in agricultural biotechnology.
  4. Studies on Model Organisms:
    Research utilizing model organisms like yeast or Drosophila for basic biological questions is less frequent, with a trend towards more complex systems that reflect human biology more closely.
  5. In Vitro Assays:
    There seems to be a decline in the publication of studies relying solely on in vitro assays without further validation in vivo, as the scientific community increasingly values comprehensive approaches that include physiological relevance.

Similar Journals

Frontiers in Bioscience-Landmark

Advancing the Frontiers of Biological Discovery
Publisher: IMR PRESSISSN: 2768-6701Frequency: 12 issues/year

Frontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.

Biochemistry and Cell Biology

Exploring the intricate dance of biochemistry and cellular mechanisms.
Publisher: CANADIAN SCIENCE PUBLISHINGISSN: 0829-8211Frequency: 6 issues/year

Biochemistry and Cell Biology, published by Canadian Science Publishing, is a prestigious journal that has been instrumental in advancing the fields of biochemistry, molecular biology, and cell biology since its inception in 1986. With an impressive scope spanning innovative research findings to comprehensive reviews, this journal serves as a vital resource for researchers, professionals, and students alike. Currently positioned in the Q2 quartile in Biochemistry and Q3 quartiles in both Cell Biology and Molecular Biology, it reflects a robust contribution to scientific discourse, placing it among reputable publications in its field. The journal boasts notable rankings within the Scopus database, highlighting its impact and relevance, and continues to be a valuable platform for disseminating pivotal research. By providing access to a wide array of articles, the journal remains committed to fostering knowledge and collaboration in the scientific community.

FASEB BioAdvances

Transforming Insights into Impactful Research
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

Cell and Bioscience

Exploring the Intersection of Science and Innovation
Publisher: BMCISSN: Frequency: 1 issue/year

Cell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.

Cell Communication and Signaling

Pioneering Research in Biochemical Pathways
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

MOLECULAR AND CELLULAR BIOCHEMISTRY

Illuminating the Path of Molecular Discoveries
Publisher: SPRINGERISSN: 0300-8177Frequency: 12 issues/year

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

Protein & Cell

Shaping the Future of Scientific Collaboration and Discussion
Publisher: OXFORD UNIV PRESSISSN: 1674-800XFrequency: 12 issues/year

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Advancing the frontiers of biochemistry and biophysics.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0006-291XFrequency: 52 issues/year

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

FEBS Open Bio

Fostering innovation through accessible research insights.
Publisher: WILEYISSN: 2211-5463Frequency: 1 issue/year

FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

CELLULAR AND MOLECULAR BIOLOGY

Transforming Knowledge in Cellular and Molecular Biology
Publisher: C M B ASSOCISSN: 0145-5680Frequency: 8 issues/year

Cellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.